A combined oral contraceptive containing drospirenone changes neither endothelial function nor hemodynamic parameters in healthy young women: A prospective clinical trial

Contraception

Volumn 86, Issue 1, 2012, Pages 35-41

  Giribela, Cassiana R G ^a   Melo, Nilson R ^a   Silva, Rita C G ^a   Hong, Valeria M ^a   Guerra, Grazia M ^a   Baracat, Edmund C ^a   Consolim Colombo, Fernanda M ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Blood pressure; Drospirenone; Endothelial function; Hemodynamic; Oral contraception

Indexed keywords

DROSPIRENONE; ETHINYLESTRADIOL; ORAL CONTRACEPTIVE AGENT;

ADULT; ARTERIAL ENDOTHELIAL FUNCTION; ARTICLE; BODY MASS; BODY WEIGHT; CELL FUNCTION; CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; HEART HEMODYNAMICS; HEART OUTPUT; HEART RATE; HUMAN; MAJOR CLINICAL STUDY; PROSPECTIVE STUDY; SYSTOLIC BLOOD PRESSURE; VASCULAR RESISTANCE; VASODILATATION;

ADULT; ALDOSTERONE ANTAGONISTS; ANDROSTENES; CONTRACEPTIVES, ORAL, COMBINED; ENDOTHELIUM, VASCULAR; ESTROGENS; ETHINYL ESTRADIOL; FEMALE; HEMODYNAMICS; HUMANS; PROSPECTIVE STUDIES;

EID: 84862008539     PISSN: 00107824     EISSN: 18790518     Source Type: Journal    
DOI: 10.1016/j.contraception.2011.08.017     Document Type: Article

References (41)

1. B.V. Stadel Oral contraceptives and cardiovascular disease (second of two parts) N Engl J Med 305 1981 672 677
2. R.T. Burkman, J.A. Collins, L.P. Shulman, and J.K. Williams Current perspectives on oral contraceptive use Am J Obstet Gynecol 185 2001 S4 S12
3. D.R. Mishell Oral contraception: past, present, and future perspectives Int J Fertil 37 Suppl 1 1992 7 18
4. J.M. Kemmeren, A. Algra, and D.E. Grobbee Third generation oral contraceptives and risk of venous thrombosis: meta-analysis BMJ 323 2001 131 134
5. J.P. Baillargeon, D.K. McClish, P.A. Essah, and J.E. Nestler Association between the current use of low-dose oral contraceptives and cardiovascular arterial disease: a meta-analysis J Clin Endocrinol Metab 90 7 2005 3863 3870
6. L. Chasan-Taber, W.C. Willett, and J.E. Manson Prospective study of oral contraceptives and hypertension among women in the United States Circulation 94 1996 483 489
7. W. Oelkers, M. Schoneshofer, and A. Blumel Effects of progesterone and four synthetic progestogens on sodium balance and the renin-aldosterone system in man J Clin Endocrinol Metab 39 1974 882 890
8. W.K. Oelkers Effects of estrogens and progestogens on the renin-aldosterone system and blood pressure Steroids 61 1996 166 171
9. N.J. Buchner, and L.C. Rump Oral contraceptives and endothelial function: harm or benefit? J Hypertens 21 2003 2227 2230
10. S. John, J. Jacobi, M.P. Schlaich, C. Delles, and R.E. Schmieder Effects of oral contraceptives on vascular endothelium in premenopausal women Am J Obstet Gynecol 183 2000 28 33
11. A. Virdis, S. Pinto, and D. Versari Effect of oral contraceptives on endothelial function in the peripheral microcirculation of healthy women J Hypertens 21 2003 2275 2280
12. B.T. Torgrimson, J.R. Meendering, P.F. Kaplan, and C.T. Minson Endothelial function across an oral contraceptive cycle in women using levonorgestrel and ethinyl estradiol Am J Physiol Heart Circ Physiol 288 2007 H103 H110
13. P.M. Lizarelli, W. Martins, and P.C.S. Vieira Both a combined oral contraceptive and depot medroxyprogesterone acetate impair endothelial function in young women Contraception 79 2009 35 40
14. J.R. Meendering, B.N. Torgrimson, N.P. Miller, P.F. Kaplan, and C.T. Minson Ethinyl estradiol-to-desogestrel ratio impacts endothelial function in young women Contraception 79 2009 41 49
15. J.R. Meendering, B.N. Torgrimson, N.P. Millera, P.F. Kaplana, and C.T. Minsona A combined oral contraceptive containing 30 μg ethinyl estradiol and 3.0 mg drospirenone does not impair endothelium-dependent vasodilation Contraception 82 2010 366 372
16. W. Oelkers, V. Berger, and A. Bolik Dihydrospirorenone, a new progestogen with antimineralocorticoid activity: effects on ovulation, electrolyte excretion and the renin-aldosterone system in normal women J Clin Endocrinol Metab 73 1991 837 842
17. W. Oelkers, J.M. Foidart, N. Dombrovicz, A. Welter, and R. Heithecker Effects of a new oral contraceptive containing an antimineralocorticoid progestogen, drospirenone, on the renin-aldosterone system, body weight, blood pressure, glucose tolerance, and lipid metabolism J Clin Endocrinol Metab 80 1995 1816 1821
18. W. Oelkers Antimineralocorticoid activity of a novel oral contraceptive containing drospirenone, a unique progestogen resembling natural progesterone Eur J Contracept Reprod Health Care 7 Suppl 3 2002 19 26
19. W. Oelkers, F.M. Helmerhorst, W. Wuttke, and R. Heithecker Effect of an oral contraceptive containing drospirenone on the renin-angiotensin-aldosterone system in healthy female volunteers Gynecol Endocrinol 14 2000 476 478
20. R.A. Preston, A. Alonso, D. Panzitta, P. Zhang, and A.H. Karara Additive effect of drospirenone/17-beta estradiol in hypertensive postmenopausal women receiving enalapril Am J Hypertens 15 2002 816 822
21. R.A. Preston, W.B. White, B. Pitt, G. Bakris, P.M. Norris, and V. Hanes Effects of drospirenone/17-beta estradiol on blood pressure and potassium balance in hypertensive postmenopausal women Am J Hypertens 18 2005 797 804
22. W.B. White, B. Pitt, R.A. Preston, and V. Hanes Antihypertensive effects of drospirenone with 17-beta-estradiol, a novel hormone treatment in post-menopausal women with stage 1 hypertension Circulation 112 2005 1979 1984
23. W.B. White, V. Hanes, V. Chauhan, and B. Pitt Effects of a new hormone therapy, drospirenone and 17-β-estradiol, in post-menopausal women with hypertension Hypertension 48 2006 246 253
24. D.A. Sica Drospirenone: an antihypertensive in waiting Hypertension 48 2006 205 206
25. T. Simoncini, X.D. Fu, and A. Caruso Drospirenone increases endothelial nitric oxide synthesis via a combined action on progesterone and mineralocorticoid receptors Hum Reprod 22 2007 2325 2334
26. World Health Organization Medical eligibility criteria for contraceptive use 4th ed. 2009 WHO Geneva (Switzerland)
27. T.G. Pickering, J.E. Hall, and L.J. Appel Recommendations for blood pressure measurement in humans and experimental animals. Part 1: blood pressure measurement in humans. A statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on high blood pressure research Hypertension 45 2005 142 161
28. E. O'Brien, F. Mee, N. Atkins, and K. O'Malley Inaccuracy of the random zero sphygmomanometer Lancet 336 1990 1465 1468
29. W.J.W. Bos, J. van Goudoever, G.A. van Montfrans, A.H. van den Meiracker, and K.H. Wesseling Reconstruction of brachial artery pressure from noninvasive finger pressure measurement Circulation 94 1996 1870 1875
30. B.P.M. Imholz, W. Wieling, G.A. van Montfrans, and F.H. Wesseling Fifteen years experience with finger arterial pressure monitoring: assessment of the technology Cardiovasc Res 38 1998 605 616
31. AAMI American National Standard ANSI/AAMI SP10-1992: electronic or automated sphygmomanometers 1993 Association for the Advancement of Medical Instrumentation Arlington (VA)
32. Finometer™ user's guide. Anhem (The Netherlands): FMS, Finapres Medical System. Copyright 2003 FMS.
33. M.C. Corretti, T.J. Anderson, and E.J. Benjamin International Brachial Artery Reactivity Task Force. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force J Am Coll Cardiol 39 2002 257 265
34. P.J. Diggle, P. Heagerty, K.Y. Liang, and S.L. Zeger Analysis of longitudinal data 2nd ed. 2002 Oxford University Press New York
35. W.O. Bussab, and P.A. Morettin Estatística básica 5th ed 2002 São Paulo Saraiva
36. P. McCullagh, and J.A. Nelder Generalized linear models 2nd ed. 1989 Chapman & Hall London
37. J.D. Gibbons, and S. Chakraborti Nonparametric statistical inference 4th ed. 2003 Marcel Dekker New York
38. J.W. Hardin, and J.M. Hilbe Generalized estimating equations 2003 Chapman & Hall London
39. U. Fuhrmann, R. Krattenmacher, E.P. Slater, and K.H. Fritzemeier The novel progestin drospirenone and its natural counterpart progesterone: biochemical profile and anti-androgenic potential Contraception 54 1996 243 251
40. W. Suthipongse, and S. Taneepanichskul An open-label randomized comparative study of oral contraceptives between medications containing 3 mg drospirenone/30 μg ethinylestradiol and 150 μg levonogestrel/30 μg ethinylestradiol Thai Women Contracept 69 2004 23 26
41. P. Hannaford Cardiovascular events associated with different combined oral contraceptives: a review of current data Drug Saf 22 2000 361 371